Publications by authors named "T Mor"

Quantum candies (qandies) represent a type of pedagogical simple model that describes many concepts from quantum information processing (QIP) intuitively without the need to understand or make use of superpositions and without the need of using complex algebra. One of the topics in quantum cryptography that has gained research attention in recent years is quantum digital signatures (QDS), which involve protocols to securely sign classical bits using quantum methods. In this paper, we show how the "qandy model" can be used to describe three QDS protocols in order to provide an important and potentially practical example of the power of "superpositionless" quantum information processing for individuals without background knowledge in the field.

View Article and Find Full Text PDF

High demand for antibodies as therapeutic interventions for various infectious, metabolic, autoimmune, neoplastic, and other diseases creates a growing need in developing efficient methods for recombinant antibody production. As of 2019, there were more than 70 FDA-approved monoclonal antibodies, and there is exponential growth potential. Despite their promise, limiting factors for widespread use are manufacturing costs and complexity.

View Article and Find Full Text PDF

The mechanism and evolution of the recognition scheme between key components of the translation system, that is, tRNAs, synthetases, and elongation factors, are fundamental issues in understanding the translation of genetic information into proteins. Statistical analysis of bacterial tRNA sequences reveals that for six amino acids, a string of 10 nucleotides preceding the tRNA 3' end carries cognate coding triplets to nearly full extent. The triplets conserved in positions 63-67 are implicated in the recognition by the elongation factor EF-Tu, and those conserved in positions 68-72, in the identification of cognate tRNAs, and their derived minihelices by class IIa synthetases.

View Article and Find Full Text PDF
Article Synopsis
  • Cocaine use disorders can lead to serious short-term issues like overdose and long-term problems such as chronic addiction, with no effective treatments currently available to reduce these risks.
  • A promising approach involves using engineered enzymes, specifically a modified form of human serum butyrylcholinesterase, to break down cocaine into inactive substances quickly.
  • A plant-derived version of this enzyme, called PCocSH, has shown success in protecting mice from cocaine overdose and preventing relapse in drug-seeking behavior, indicating its potential as a therapeutic option for treating cocaine use disorders in humans.
View Article and Find Full Text PDF